• Focusing on the diagnosis and treatment of difficult and severe Hematologic Diseases such as leukemia, lymphoma, multiple myeloma, and thalassemia.
  • Providing accurate diagnosis and individualized treatment. Individualizing the diagnosis and treatment plan for each patient by an effective combination of chemotherapy, radiotherapy, immunotherapy, targeted therapy, hematopoietic stem cell transplant and other technologies.
  • Expanding the clinical application and research of CAR-T, innovative drugs and other advanced technologies to obtain more treatment options for refractory and relapsed patients.
  • Safeguarding the whole treatment period for patients through efficient collaboration of the multidisciplinary team.


    Remote Second Opinion